| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.078 | 0.2 |